Pironip 20mg Tablet DT
Marketer
Avonic Life Sciences
Salt Composition
Piroxicam (20mg)
Overview Pironip 20mg Tablet DT
Anarex 20mg Delayed-Release Tablets provide pain relief. Indicated for moderate to severe pain associated with conditions like osteoarthritis and rheumatoid arthritis, it alleviates joint and muscle pain and inflammation. Administer Anarex 20mg with food to minimize gastrointestinal discomfort. Dosage and treatment length vary depending on individual response and the specific condition. Continue treatment as prescribed, even with symptom improvement, until your physician advises discontinuation. Common side effects may include mild nausea, vomiting, stomach ache, headache, and lightheadedness. Report persistent or worsening side effects to your doctor, who can offer management strategies. Prior to use, inform your doctor of any pre-existing conditions, such as stomach ulcers, cardiovascular disease, hypertension, or liver/kidney impairment. Disclose all other medications you are currently taking, as interactions may occur. Consult your doctor before using Anarex if you are pregnant or breastfeeding.
Uses of Pironip 20mg Tablet DT
Analgesia
Major Benefits of Pironip 20mg Tablet DT:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Dissolve the tablet in water before ingestion. It's recommended to take the Pironip 20mg Tablet DT with a meal.
Common Side effects of Pironip 20mg Tablet DT:
- Vomiting
- Stomach pain
- Nausea
- Headache
- Dizziness
How to use Pironip 20mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Pironip 20mg Tablet DT in water before consumption. Administer this medication with a meal.
How Pironip 20mg Tablet DT works:
Deltan 20mg Extended-Release Tablets are a non-steroidal anti-inflammatory medication, inhibiting the production of inflammatory mediators to alleviate pain and edema.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Pironip 20mg Tablet DT is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Pironip 20mg DT tablets during pregnancy carries a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Using Pironip 20mg Tablet DT while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Pironip 20mg extended-release tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Pironip 20mg Tablet DT. Dosage modification of Pironip 20mg Tablet DT might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Pironip 20mg Delayed-Release Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Pironip 20mg Tablet DT :
Should you forget a dose of Pironip 20mg Tablet DT, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pironip 20mg Tablet DT
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from enolic acids |
| Potential for Dependence | None. |
| Type of Medication | Pain relievers |
FAQs on Pironip 20mg Tablet DT
Pironip 20mg Tablet DT and diclofenac are analgesics. Piroxicam, the active ingredient in Pironip 20mg Tablet DT, non-selectively inhibits COX enzymes, which mediate inflammation and pain. In contrast, diclofenac exhibits greater selectivity for COX-2. This enhanced selectivity in diclofenac is believed to reduce the incidence of adverse reactions relative to Pironip 20mg Tablet DT.
Pironip 20mg Tablet DT and naproxen are analgesics, both non-selectively inhibiting COX enzymes, which mediate inflammation and pain. Clinical trials indicate comparable efficacy for both drugs. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse events than Pironip 20mg Tablet DT.
Pironip 20mg Tablet DT and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse events than Pironip 20mg Tablet DT.
Pironip 20mg Tablet DT and ketoprofen are both nonsteroidal anti-inflammatory drugs (NSAIDs) that alleviate pain by inhibiting cyclooxygenase (COX), an enzyme involved in inflammation and pain sensation. Clinical trials indicate superior efficacy and tolerability for topical ketoprofen gel relative to Pironip 20mg Tablet DT.
Pironip 20mg Delayed-Release Tablets target cyclooxygenase (COX), an enzyme mediating inflammation and pain. In contrast, Tramadol functions as an opioid analgesic. Tramadol carries a risk of dependence.
Pironip 20mg Tablet DT and nimesulide are analgesics. Pironip 20mg Tablet DT, unlike nimesulide, non-selectively inhibits COX enzymes, crucial in inflammation and pain mediation. Nimesulide's selective COX-2 inhibition theoretically reduces adverse reactions compared to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't reduce platelet levels. However, analgesics such as piroxicam may heighten the risk of bleeding. Therefore, avoid Pironip 20mg Tablet DT or other pain relievers if you experience fever with joint pain. Seek medical advice before commencing Pironip 20mg Tablet DT.
Pironip 20mg Tablets DT and aspirin are distinct medications, despite both being COX (cyclooxygenase) inhibitors. Both drugs exhibit anti-inflammatory and analgesic properties.
Concomitant administration of Pironip 20mg Delayed-Release Tablets and dexamethasone is contraindicated due to the potential for synergistic toxicity, notably heightened gastrointestinal ulcer risk.
Concurrent use of methocarbamol and Pironip 20mg Tablet DT is considered safe, lacking documented significant adverse interactions. However, physician consultation is recommended prior to initiating either treatment.
Confirmation: Concurrent use of paracetamol and Pironip 20mg DT tablets is acceptable, as no significant adverse reactions have been documented. Physician consultation is advised prior to initiating either treatment.
Indeed, Pironip 20mg Delayed-Release Tablets are classified as a non-steroidal anti-inflammatory drug.
The drug Pironip 20mg Tablet DT, a sulfur-based medication, may induce severe adverse reactions in susceptible patients. These reactions can include serious dermatological conditions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Pironip 20mg Delayed-Release Tablets do not possess anticoagulant properties; they are an analgesic. Patients with hemorrhagic conditions should refrain from using this medication.
Pironip 20mg Tablet DT does not relax muscles. This analgesic targets COX (cyclooxygenase), an enzyme that contributes to inflammation and pain.
Pironip 20mg DT tablets are non-narcotic analgesics. Their pain-relieving action targets COX enzymes (cyclooxygenases), which mediate inflammation and pain, thereby reducing both.
Pironip 20mg Tablet DT does not treat high blood pressure. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose current antihypertensive medication use to your physician prior to commencing Pironip 20mg Tablet DT therapy.
Concomitant use of Pironip 20mg Tablet DT and Losartan is contraindicated. Pironip 20mg Tablet DT diminishes the efficacy of antihypertensive agents such as Losartan, potentially rendering antihypertensive treatment ineffective. Disclose any current antihypertensive medication use to your physician prior to commencing Pironip 20mg Tablet DT therapy.
Concurrent use of Pironip 20mg Tablet DT and lisinopril is contraindicated. Piroxicam, the active ingredient in Pironip, diminishes the efficacy of antihypertensive drugs such as lisinopril, potentially rendering antihypertensive treatment ineffective. Patients using antihypertensive medications should disclose this to their physician prior to commencing Pironip 20mg Tablet DT therapy.
Pironip 20mg Delayed-Release Tablets may be used concurrently with calcium channel blockers. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) can diminish the efficacy of most antihypertensive medications, although this effect is not seen with calcium channel blockers (White, 2007).
Pironip 20mg Tablet DT may be used concurrently with tizanidine. Piroxicam, an analgesic, and the muscle relaxant tizanidine are compatible; this combination is suitable for conditions such as back pain.
Affirmative. Concomitant administration of Pironip 20mg Tablet DT and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Indeed, viable substitutes for Pironip 20mg extended-release tablets exist. Analgesic selection depends on the specific ailment. Physician consultation is necessary before initiating piroxicam therapy or switching to an alternative treatment.
Piroxicam should not be used in individuals with allergies, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Pironip 20mg Tablet DT does not alleviate allergic reactions; it is an analgesic.
Pironip 20mg DT tablets provide extended-duration pain relief. A single daily dose often suffices, though individual responses vary; piroxicam's analgesic effect generally improves with continued use over several weeks.
Pironip 20mg Delayed-Release Tablets are not associated with hypertension. This medication is a non-opioid analgesic.
The drug Pironip 20mg Tablet DT lacks regulatory approval for managing dysmenorrhea. However, clinical trials indicate piroxicam's substantial efficacy in reducing menstrual pain.
The medication Pironip 20mg Tablet DT lacks regulatory approval for migraine management. However, clinical trials indicate its efficacy in substantially reducing migraine pain in individuals without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's consultation is crucial to determine the underlying cause of your back pain before commencing treatment. Avoid self-treating with Pironip 20mg Tablet DT, as the etiology of back pain varies individually.
Acute gout can be treated with Pironip 20mg Tablet DT. Clinical trials demonstrate the significant efficacy of Pironip 20mg Tablet DT in managing acute gout episodes.
Blood donation is permissible while taking Pironip 20mg Tablet DT; however, it's crucial to disclose this medication use to your physician prior to donation.
The use of Pironip 20mg Tablet DT by individuals with diabetes requires prior medical consultation. Prolonged use of this medication carries a significant risk of kidney damage. Since diabetes itself elevates the risk of kidney disease, adding piroxicam substantially increases this risk.
Patients with impaired kidney function should avoid Pironip 20mg Delayed-Release Tablets. Prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) has been linked to kidney damage, including papillary necrosis.
Affirmative. The medication Pironip 20mg Tablet DT has been associated with potentially severe cutaneous adverse reactions, including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be life-threatening. These serious reactions may develop unexpectedly. Report any minor skin eruption to your physician and cease taking the drug immediately.
The use of Pironip 20mg Delayed-Release Tablets is contraindicated during pregnancy. Administration may result in premature ductus arteriosus closure, potentially causing fetal cardiac failure and mortality.
Pironip 20mg Tablet DT is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and bleeding.
Individuals with asthma may experience heightened sensitivity to nonsteroidal anti-inflammatory medications (NSAIDs), such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing treatment with these drugs.
Confirmed. The 20mg delayed-release Pironip tablet may induce temporary infertility in some cases. Piroxicam's mode of action can hinder or postpone ovarian follicle rupture, a factor linked to reversible infertility. Physician consultation is advised prior to initiating this treatment.
Concomitant administration of Pironip 20mg Tablet DT and diuretics is contraindicated. In certain individuals, Pironip 20mg Tablet DT diminishes the sodium-excreting action of furosemide and thiazide diuretics. This interaction is believed to result from suppressed renal prostaglandin production.
Concurrent use of Pironip 20mg Tablet DT and lithium is contraindicated. Pironip 20mg Tablet DT increases lithium plasma concentrations and decreases renal lithium excretion. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Pironip 20mg Tablet DT therapy.
Concurrent use of Pironip 20mg Delayed-Release tablets and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before taking Pironip. If co-administered, close medical supervision is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, smoking, and advanced age also contribute to increased ulceration probability.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), or those who experienced such reactions immediately before or following coronary artery bypass grafting.
Stomach upset is possible, and in rare instances, severe gastrointestinal complications including ulcers and hemorrhage may occur. Serious skin reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis are also potential adverse effects, as are liver damage and kidney impairment.
3,018 People bought this recently
Pironip 20mg Tablet DT
31
MRP 38
18% off